Clinical trials: Behavioural Emergency
Migraine, Hemicrania
Home Detox in Medication Overuse Headache (MOH) During Covid-19 Emergency
Medication Overuse Headache (MOH) is a disabling condition that affects the 2% of migraine population. Medication overuse (MO) makes this condition very difficult to treat.
- Trial name
- MOHC (NCT04410536)
- Testing
- Symptomatic drugs, Bridge therapy, Mindfulness program
- Where
- Italy
- Volunteers
- 25 people, healthy volunteers welcome
- Sponsor
- Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
Acute Agitation, Behavioural Emergency
IM Olanzapine Versus Haloperidol or Midazolam
The purpose of this study is to determine whether intramuscular olanzapine is safer (fewer adverse events) and more effective (shorter time to sedation) than conventional haloperidol or midazolam when used in the management of…
- Trial name
- NCT02380118
- Testing
- Olanzapine, Haloperidol, Midazolam
- Where
- 6 sites in Hong Kong
- Volunteers
- 167 people
- Sponsor
- The University of Hong Kong
Smoking Cessation, Electronic Cigarette Use
Cessation of Smoking Trial in the Emergency Department
The Cessation of Smoking Trial in the Emergency Department (CoSTED) is an National Institute for Health Research (NIHR) Health Technology Assessment (HTA) funded randomised controlled trial (RCT).
- Conditions
- Smoking Cessation, Electronic Cigarette Use, E-Cig Use, Vaping
- Trial name
- COSTED (NCT04854616)
- Testing
- CoSTED Intervention
- Where
- United Kingdom
- Volunteers
- 972 people, healthy volunteers welcome
- Sponsor
- Norfolk and Norwich University Hospitals NHS Foundation Trust
Autism Spectrum Disorder
The BRAVE (Behaviourally Responsive Assessments of Vital Signs in Emergency) Study
This is a randomized, unblinded, single-centre, pilot feasibility study. A total of 100 patients will be enrolled and randomized to have their vital signs collected using either the Masimo Radius PPG and Radius T in combination…
- Trial name
- BRAVE (NCT07828964)
- Testing
- wearable vital sign device
- Volunteers
- 100 people
- Sponsor
- Hamilton Health Sciences Corporation
Acute Agitation, Behavioural Emergency
Oral Olanzapine Versus Haloperidol or Diazepam
The purpose of this study is to determine whether oral olanzapine is safer (fewer adverse events) and more effective (shorter time to sedation) than conventional haloperidol or diazepam when used in the management of acute…
- Trial name
- NCT03246620
- Testing
- Olanzapine oro-dispersible 5Mg Tab, Haloperidol 2Mg encapsulated Tab, Diazepam 2Mg encapsulated Tab
- Where
- Hong Kong
- Volunteers
- 12 people
- Sponsor
- The University of Hong Kong